MAGERY SATISH: Open Payments
NPI 1730228800 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 29 payments from 8 companies in 2025. Trend: 2023 $793 · 2024 $420 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $164 |
| Alkermes, Inc. | 5 | $138 |
| E.R. Squibb & Sons, L.L.C. | 5 | $87 |
| Lundbeck LLC | 3 | $78 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Corium, LLC | 3 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: CAPLYTA, ARISTADA, COBENFY, REXULTI, Auvelity, Azstarys, ABILIFY ASIMTUFII, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
